Apellis Pharmaceuticals, Inc. (APLS) vs BridgeBio Pharma, Inc. (BBIO)
Detailed comparison between Apellis Pharmaceuticals, Inc., BridgeBio Pharma, Inc..Total Return (%)
Apellis Pharmaceuticals, Inc. (APLS)BridgeBio Pharma, Inc. (BBIO)
Which stock do you think will perform better?
Apellis Pharmaceuticals, Inc.
APLS
BridgeBio Pharma, Inc.
BBIO
| Metric | Apellis Pharmaceuticals, Inc. (APLS) | BridgeBio Pharma, Inc. (BBIO) |
|---|---|---|
| Current Price | $27.41 | $36.25 |
| Change | -0.11 (-0.40%) | -0.60 (-1.63%) |
| Market Cap | $3.41B | $6.89B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -32.63 | -11.85 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $71.90 | $39.47 |
| 52-Week Low | $24.34 | $21.62 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-2.03 | $-2.88 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| APLS | -7.99% | -7.99% | -61.79% | -20.57% | 95.37% | 95.37% |
| BBIO | -1.15% | -1.15% | 3.96% | 13.49% | 31.58% | 31.58% |